Lim SH, An M, Lee H, Heo YJ, et al. Determinants of Response to Sequential Pembrolizumab with Trastuzumab plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial. Clin Cancer Res 2025 Mar 18:OF1-OF15. doi: 10.1158/1078-0432.CCR-24-3528.
PMID: 40100100